not tagged
not tagged
['pancreatic', 'sclc', 'nsclc']
#asco22 cohort 1 data here includes 15 patients (safety population = 35), primarily nsclc and one pancreatic. likely reflects testing practice (#nrg1 fusions much easier to find on rna-seq due to massive intronic regions). well tolerated (6% dose reduction, no d/c for aes). 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him